Homebiotech

biotech

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

biotech

Elite immune cells lead fight against multiple myeloma

Jim Cornall - May 25, 2026

biotech

Soin Neuroscience and Lilac Biosciences to collaborate to study RNA signatures in pain and neuromodulation

Jim Cornall - February 16, 2026

biotech

Base to Base biotech podcast 46: Endometriosis and closing care gaps

Jim Cornall - February 13, 2026

biotech

Calla Lily Clinical Care and Merck to collaborate on intravaginal drug delivery platform

Jim Cornall - February 12, 2026

biotech

Body’s own defence may be the key to longer cancer survival

Jim Cornall - February 12, 2026

biotech

Zonsen PepLib Biotech to collaborate with Lilly

Jim Cornall - February 12, 2026

biotech

World-first personalised paediatric mRNA cancer vaccine trial

Jim Cornall - February 11, 2026

biotech

Orphan Drug Designation for cholangiocarcinoma treatment

Jim Cornall - February 11, 2026

biotech

Yeast cells can be used for rapid testing of cancer immunotherapy

Jim Cornall - February 11, 2026

1...222324...78 Page 23 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026 0

OSE Immunotherapeutics SA has announced the release of the abstract selected for an oral presentation at the upcoming ASCO 2026 annual meeting, unveiling topline...

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0

National framework to strengthen UK advanced therapy clinical trials

biotech Jim Cornall - May 25, 2026 0